The system is extremely sensitive: it can detect drugs in amounts 100 times lower than the clinically delivered drug concentrations commonly used
Today, computerized smart systems can deliver drugs intravenously in exact volumes to hospital patients. However, these systems cannot recognize which medications are in the tubing nor can they determine the concentration of the drug in the tubing. This lack of precise information can lead to medication errors with serious consequences.
Now, a new optical device developed by a team of electrical and computer engineering students at the University of Illinois at Urbana-Champaign (UIUC) can identify the contents of the fluid in an intravenous (IV) line in real-time, offering a promising way to improve the safety of IV drug delivery. The team, led by Prof. Brian T. Cunningham, interim director of the Micro and Nanotechnology Laboratory at UIUC, will present its work at The Optical Society’s (OSA) Annual Meeting, Frontiers in Optics (FiO) 2013, being held Oct. 6-10 in Orlando, Fla.
The vulnerability of IV drug-delivery systems due to human error is a chief concern in hospital safety, Cunningham said. Errors can include incorrect dosage, unintentional substitution of one drug for another, and co-delivery of incompatible drugs.
“Up to 61 percent of all life-threatening errors during hospitalization are associated with IV drug therapy,” Cunningham said, citing a recent report. “So for all the really good things hospitals can do, the data shows that mistakes can occasionally happen.”
To approach this problem, Cunningham and colleagues turned to the very small – to structures and processes at the nanoscale (one-billionth of a meter), where novel physical and chemical properties arise. The researchers use a technology called Surface-Enhanced Raman Scattering (SERS), a powerful analytical tool prized for its extreme sensitivity in obtaining molecular signals that can be used to identify chemicals. To determine the identity of a particular IV medication, researchers shine laser light onto a nanostructured gold surface that contains millions of tiny “nano-domes” that are separated from each other by as little as 10 nanometers. The nano-domes are incorporated into the inner surface of IV tubing, where they are exposed to drugs that are dispersed in liquid. They capture the light scattered from drug molecules that are in contact with the nano-domes and use SERS to determine the drug’s molecular signature. Finally, they match the signature to known signatures for the drug in order to confirm the presence of a specific medication in the IV line.
While other groups have demonstrated excellent nanostructured surfaces for SERS, those developed by the Cunningham group are unique because they are inexpensively produced on flexible plastic surfaces by a replica molding process with nanometer scale accuracy.
Early data show that the Cunningham group’s system can identify medications including morphine, methadone, phenobarbital, the sedative promethazine, and mitoxantrone, which is used to treat multiple sclerosis. The system is extremely sensitive: it can detect drugs in amounts 100 times lower than the clinically delivered drug concentrations commonly used. So far, the researchers have also shown their system can sense a two-drug combination, which has its own unique signature.
The next step is further evaluation for combinations of up to ten drugs being delivered at the same time.
The Latest on: Detector for IV delivered drugs
via Google News
The Latest on: Detector for IV delivered drugs
- Global Anesthesia Drugs Market 2021 Global Trends, Emerging Technologies And Growth Analysis By Forecast To 2022on January 23, 2021 at 5:55 am
Jan (Heraldkeepers) -- Global Anesthesia Drugs Market 2020, on a global basis, offering a forecast and statistic in terms of revenue during ...
- H|T: The Healthtech Times – Blunder drugon January 22, 2021 at 3:03 am
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the ...
- Drugs destined for Clare seized by Revenueon January 22, 2021 at 1:51 am
A QUANTITY of drugs that were on their way to Clare were seized by Revenue officers at the Dublin Mail Centre on Thursday. Officers, with the help of detector dogs, seized over 1.5kg of illegal drugs, ...
- Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claimson January 21, 2021 at 11:11 am
An unusual experiment to prevent nursing home staff members and residents from infection with the coronavirus has succeeded, the drug maker Eli Lilly announced on Thursday. A drug containing ...
- More than €32,000 worth of suspected drugs seized in Dublinon January 21, 2021 at 10:50 am
More than €32,000 worth of suspected drugs has been seized at Dublin Mail Centre. Revenue said that the drugs were discovered in parcels that originated in the United States and the UK and were ...
- Cannabis 'jelly sweets' among €32,000 drug haul seized by Revenue in Dublinon January 21, 2021 at 10:33 am
Cannabis infused "jelly sweets" were among a 1.5kg drug haul worth more than €32,000 seized in Dublin this afternoon. The sweets and other illegal drugs were discovered at the Dublin Mail Centre by ...
- Eli Lilly: Drug can prevent COVID-19 illness in nursing homeson January 21, 2021 at 4:13 am
Residents and staff who got the drug had up to a 57% lower risk of getting COVID-19 compared to others at the same facility who got a placebo, the drugmaker said.
- Top Key Companies of Drug Delivery Systems Market are Boston Scientific Corporation, Johnson and Johnson Services, Inc., Pfizer, Inc.on January 19, 2021 at 4:00 pm
The ongoing COVID-19 pandemic is set to leverage the global drug delivery systems market, expanding at a CAGR of 7.0% between 2020 and 2025. As the number of infections rise exponentially on a daily ...
- U.S. health officials push hospitals to administer unused Covid antibody drugson January 15, 2021 at 4:00 am
Top U.S. health officials said Covid antibody drugs are being underutilized, and they urged hospitals to prescribe the drugs much more frequently.
- Insights on the RNA Interference (RNAi) Drug Delivery Global Market to 2025 - Impact Analysis of COVID-19on January 4, 2021 at 7:58 am
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
via Bing News